Results 141 to 150 of about 3,203,567 (223)
Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms.
American Journal of Health-System Pharmacy, 1979 The types of extrapyramidal syndrome (EPS) reactions produced by antipsychotic agents and the prophylactic use of antiparkinson agents in preventing EPS are reviewed. EPS are classified as akathisias, dystonias, parkinson-like symptoms and tardive dyskinesia, and have a varied incidence reported to range from 10.6 to 100%.
John E. Murphy, Ronald B. Stewart
semanticscholar +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Carotenoids as Antiparkinson Agents
, 2021Parkinson’s disease (PD) is a neurodegenerative disease associated with the loss of dopaminergic neurons in the portions of the brain via multiple pathological mechanisms. Despite the fact that enormous progress occurred in the cure of Parkinson’s disorder, but the incidence and risk of this disease is increasing alarmingly over the past few decades ...
S. Dewanjee +5 more
semanticscholar +3 more sources
Potential for abuse of antiparkinson agents.
Psychiatric Services, 1982Hospital &‘ Community Psychiatrj is expanding its roster of peer reviewers for manuscripts submitted for publication. Professionals in the mental health disciplines who are qualified to serve as peer reviewers are invited to contact the editor. Reviewers must have significant publications in their specialty area, be abreast of the liteEature in that ...
J. M. Smith
semanticscholar +4 more sources
ChemInform Abstract: SOME NEW PIPERAZINO DERIVATIVES AS ANTIPARKINSON AND ANTICONVULSANT AGENTS
Archiv der Pharmazie, 1983 AbstractThe piperazino derivatives 1–7 were synthesized and evaluated for their antiparkinson activity on oxotremorine‐induced tremors and reserpine‐induced rigidity. The same compounds were screened for their anticonvulsant activity. Compounds 1, 3, 4 and 5 showed promising antiparkinson activity.
Jolly Agarwal +5 more
openalex +5 more sources
Reactions to Antiparkinson Agents
, 1987The cardiovascular effects are dose-related. Low doses can cause transient bradycardia; moderate or high doses can cause tachycardia, palpitation, and arrhythmias (due to blockage of vagal effects on the S-A node).
F. L. Tornatore +3 more
semanticscholar +3 more sources
REVERSAL OF SOME THERAPEUTIC EFFECTS OF AN ANTIPSYCHOTIC AGENT BY AN ANTIPARKINSONISM DRUG
The Journal of Nervous and Mental Disease, 1973 Data are presented from a multidimensional, longitudinal study in 10 acute schizophrenics which indicate that the addition of benztropine to haloperidol reversed the course of some of the therapeutic changes. The nontherapeutic interaction was selective involving what may be called social avoidance behavior but not the cognitive integrative ...
Man Mohan Singh, James M. Smith
openalex +4 more sources
Quantitative Determination of Some Synthetic Antiparkinsonism Agents
Journal of Pharmaceutical Sciences, 1968 Nonaqueous titrimetry was employed to estimate quantitatively some of the compounds which are useful in treating Parkinsonism. The method was applied to both the crystalline material and their dosage forms. This technique was found to yield results which agreed well with those obtained by either the official procedures or by methods submitted by the ...
L.G. Chatten, William J. Racz
openalex +4 more sources
[Immunotropic activity of a potential antiparkinson agent himantane].
Eksperimental'naia i klinicheskaia farmakologiia, 2001 N-(Adamant-2-yl) hexamethyleneimine hydrochloride (A-7, himantane), a new potential antiparkinsonian drug belonging to the class of aminoadamantyl derivatives, exhibits pronounced immunomodulant activity in a therapeutic dose of 10 mg/kg. A single intraperitoneal injection of himantane stimulated a high B-lymphocyte activity in mice over a period of 21
G I Nezhinskaia +3 more
openalex +2 more sources
Potential antiparkinsonism agents. Quinuclidinyl benzhydryl ethers
Journal of Medicinal Chemistry, 1969 Jonas Nilsson +2 more
openalex +4 more sources